INDP
Indaptus Therapeutics Inc
2.50$
+5.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.3% | +129.7% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -2.5% | +3.9% | +1.1% | -43.3% | -31.5% | -20.8% | -25.0% | -16.7% | +421.7% | -71.1% | -128.3% | – | |
| – | – | -238.2% | – | -85.2% | +285.6% | -275.2% | – | -155.5% | – | -216.6% | – | – | |
| – | – | -100.0% | – | -100.0% | – | -100.0% | – | – | -100.0% | – | -100.0% | – | |
| – | -100.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -88.0% | +6,709.5% | -30.5% | +74.9% | +99.4% | -56.7% | +115.7% | -100.0% | – | – | |
| – | -179.7% | – | – | – | -2,119.3% | – | – | -114.6% | – | -361.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.